DK3408292T3 - Splittede inteiner med ganske særlig splejseaktivitet - Google Patents

Splittede inteiner med ganske særlig splejseaktivitet Download PDF

Info

Publication number
DK3408292T3
DK3408292T3 DK17745022.8T DK17745022T DK3408292T3 DK 3408292 T3 DK3408292 T3 DK 3408292T3 DK 17745022 T DK17745022 T DK 17745022T DK 3408292 T3 DK3408292 T3 DK 3408292T3
Authority
DK
Denmark
Prior art keywords
inteins
spliced
splicing activity
special splicing
special
Prior art date
Application number
DK17745022.8T
Other languages
Danish (da)
English (en)
Inventor
Tom W Muir
Adam J Stevens
Neel H Shah
Original Assignee
Univ Princeton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Princeton filed Critical Univ Princeton
Application granted granted Critical
Publication of DK3408292T3 publication Critical patent/DK3408292T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/90Fusion polypeptide containing a motif for post-translational modification
    • C07K2319/92Fusion polypeptide containing a motif for post-translational modification containing an intein ("protein splicing")domain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
DK17745022.8T 2016-01-29 2017-01-27 Splittede inteiner med ganske særlig splejseaktivitet DK3408292T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662288661P 2016-01-29 2016-01-29
PCT/US2017/015455 WO2017132580A2 (en) 2016-01-29 2017-01-27 Split inteins with exceptional splicing activity

Publications (1)

Publication Number Publication Date
DK3408292T3 true DK3408292T3 (da) 2023-06-12

Family

ID=59398921

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17745022.8T DK3408292T3 (da) 2016-01-29 2017-01-27 Splittede inteiner med ganske særlig splejseaktivitet

Country Status (14)

Country Link
US (2) US11142550B2 (enExample)
EP (2) EP3408292B1 (enExample)
JP (1) JP7290305B2 (enExample)
CN (1) CN108884154A (enExample)
AU (1) AU2017211395B2 (enExample)
CA (1) CA3051195A1 (enExample)
DK (1) DK3408292T3 (enExample)
ES (1) ES2949163T3 (enExample)
FI (1) FI3408292T3 (enExample)
HU (1) HUE062276T2 (enExample)
PL (1) PL3408292T3 (enExample)
PT (1) PT3408292T (enExample)
SI (1) SI3408292T1 (enExample)
WO (1) WO2017132580A2 (enExample)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2734621B1 (en) 2011-07-22 2019-09-04 President and Fellows of Harvard College Evaluation and improvement of nuclease cleavage specificity
EP2986635B1 (en) 2013-04-18 2018-10-03 Fondazione Telethon Effective delivery of large genes by dual aav vectors
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9340800B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College Extended DNA-sensing GRNAS
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9840699B2 (en) 2013-12-12 2017-12-12 President And Fellows Of Harvard College Methods for nucleic acid editing
WO2016022363A2 (en) 2014-07-30 2016-02-11 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
WO2017011550A1 (en) 2015-07-13 2017-01-19 University Of Utah Research Foundation Methods of making red blood cells and platelets in vitro and uses thereof
IL258821B (en) 2015-10-23 2022-07-01 Harvard College Nucleobase editors and their uses
PL3408292T3 (pl) * 2016-01-29 2023-10-02 The Trustees Of Princeton University Podzielone inteiny o wyjątkowej aktywności splicingu
KR20250103795A (ko) 2016-08-03 2025-07-07 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 아데노신 핵염기 편집제 및 그의 용도
CA3033327A1 (en) 2016-08-09 2018-02-15 President And Fellows Of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
JP7588390B2 (ja) 2016-10-14 2024-11-22 プレジデント アンド フェローズ オブ ハーバード カレッジ 核酸塩基エディターのaav送達
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
CN110662556A (zh) 2017-03-09 2020-01-07 哈佛大学的校长及成员们 癌症疫苗
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
JP2020510439A (ja) 2017-03-10 2020-04-09 プレジデント アンド フェローズ オブ ハーバード カレッジ シトシンからグアニンへの塩基編集因子
BR112019019655A2 (pt) 2017-03-23 2020-04-22 Harvard College editores de nucleobase que compreendem proteínas de ligação a dna programáveis por ácido nucleico
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
JP2020534795A (ja) 2017-07-28 2020-12-03 プレジデント アンド フェローズ オブ ハーバード カレッジ ファージによって支援される連続的進化(pace)を用いて塩基編集因子を進化させるための方法および組成物
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
KR20250107288A (ko) 2017-10-16 2025-07-11 더 브로드 인스티튜트, 인코퍼레이티드 아데노신 염기 편집제의 용도
WO2019118949A1 (en) 2017-12-15 2019-06-20 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
WO2019226953A1 (en) 2018-05-23 2019-11-28 The Broad Institute, Inc. Base editors and uses thereof
KR102894715B1 (ko) 2018-08-03 2025-12-03 빔 테라퓨틱스, 인크. 핵산 표적 서열을 변형시키기 위한 다중-이펙터 핵염기 편집기 및 이를 이용하는 방법
US11530245B2 (en) * 2018-08-31 2022-12-20 Washington University Split intein mediated polymerization and production of mussel foot adhesive protein materials
WO2020051562A2 (en) 2018-09-07 2020-03-12 Beam Therapeutics Inc. Compositions and methods for improving base editing
IL320368A (en) * 2018-10-15 2025-06-01 Fond Telethon Ets Intein proteins and their uses
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
LU101118B1 (en) * 2019-02-06 2020-08-06 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Method for detecting a specific splice event of a gene of interest
EP3942042A1 (en) 2019-03-19 2022-01-26 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
EP3956349A1 (en) 2019-04-17 2022-02-23 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
CN110714020B (zh) * 2019-05-22 2021-08-03 北京理工大学 一种高效简便纯化蛋白的方法
WO2021016075A1 (en) 2019-07-19 2021-01-28 Flagship Pioneering Innovations Vi, Llc Recombinase compositions and methods of use
WO2021040703A1 (en) * 2019-08-28 2021-03-04 The Trustees Of Princeton University Atypical split inteins and uses thereof
WO2021047559A1 (zh) * 2019-09-09 2021-03-18 武汉友芝友生物制药有限公司 一种断裂型内含肽、使用其的重组多肽的制备方法
KR20220070481A (ko) * 2019-10-01 2022-05-31 유타대학연구재단 순환 종양 세포를 표적화하기 위한 혈소판 조작 방법
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
GB201917046D0 (en) * 2019-11-22 2020-01-08 Ge Healthcare Bioprocess R&D Ab Improved protein production
MX2022010991A (es) 2020-03-04 2023-02-09 Flagship Pioneering Innovations Vi Llc Metodos y composiciones para modular un genoma.
CN111235174A (zh) * 2020-03-11 2020-06-05 梦芊科技知识产权有限公司 利用枯草芽孢杆菌和核酸内切酶制备人碱性成纤维细胞生长因子
EP3885440A1 (en) * 2020-03-26 2021-09-29 Splicebio, S.L. Split inteins and their uses
WO2021226558A1 (en) 2020-05-08 2021-11-11 The Broad Institute, Inc. Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
US20230227508A1 (en) 2020-06-12 2023-07-20 Massachusetts Institute Of Technology Split intein-based selection for peptide binders
US20250282815A1 (en) * 2021-05-12 2025-09-11 Cytiva Bioprocess R&D Ab Improved protein purification
CN113735941B (zh) * 2021-08-13 2024-01-30 江南大学 一种蛋白纯化方法及其应用
KR102663243B1 (ko) * 2021-08-30 2024-05-03 국립순천대학교산학협력단 트립신 특이적 형광 프로브 및 이의 용도
JP2024533311A (ja) 2021-09-08 2024-09-12 フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー ゲノムを調節するための方法及び組成物
WO2023081714A1 (en) * 2021-11-02 2023-05-11 Cornell University Intein systems and uses thereof
CN119630796A (zh) * 2022-05-26 2025-03-14 国立大学法人山形大学 异二聚体蛋白质的制造方法、二聚体蛋白质、单体蛋白质,以及靶标反应性异二聚体蛋白质的筛选方法
EP4594486A2 (en) * 2022-09-26 2025-08-06 Beam Therapeutics Inc. Synthetic polypeptides and uses thereof
WO2024097763A1 (en) * 2022-11-01 2024-05-10 Memorial Sloan-Kettering Cancer Center Intein-based sorting system and modular chimeric polypeptides
WO2024170051A1 (en) * 2023-02-13 2024-08-22 Kutzner Christoph Fusion polypeptides for manufacturing of cyclic peptides
WO2024258785A1 (en) 2023-06-11 2024-12-19 Regeneron Pharmaceuticals, Inc. Circularized antibody molecules
WO2025051758A1 (en) 2023-09-04 2025-03-13 Splicebio, Sl Use of split intein for the treatment of scn1a associated disease
WO2025153705A1 (en) 2024-01-18 2025-07-24 Splicebio, Sl Use of split intein for the treatment of myo7a-associated disease
WO2025194124A1 (en) 2024-03-14 2025-09-18 Tessera Therapeutics, Inc. Modified st1cas9 guide nucleic acids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2618632T3 (es) * 2011-09-28 2017-06-21 Zera Intein Protein Solutions, S.L. Inteínas divididas y usos de éstas
JP2015522020A (ja) 2012-06-27 2015-08-03 ザ・トラスティーズ・オブ・プリンストン・ユニバーシティThe Trustees Of Princeton University スプリットインテイン、複合体およびそれらの使用
US10087213B2 (en) * 2013-01-11 2018-10-02 The Texas A&M University System Intein mediated purification of protein
PL3408292T3 (pl) * 2016-01-29 2023-10-02 The Trustees Of Princeton University Podzielone inteiny o wyjątkowej aktywności splicingu

Also Published As

Publication number Publication date
FI3408292T3 (fi) 2023-06-30
EP3408292A4 (en) 2019-09-18
CA3051195A1 (en) 2017-08-03
JP2019506163A (ja) 2019-03-07
PL3408292T3 (pl) 2023-10-02
EP4234689A2 (en) 2023-08-30
US20210371467A1 (en) 2021-12-02
AU2017211395B2 (en) 2024-04-18
EP3408292A2 (en) 2018-12-05
WO2017132580A3 (en) 2017-09-14
SI3408292T1 (sl) 2023-09-29
EP3408292B1 (en) 2023-04-26
EP4234689A3 (en) 2023-09-13
CN108884154A (zh) 2018-11-23
JP7290305B2 (ja) 2023-06-13
US11142550B2 (en) 2021-10-12
HUE062276T2 (hu) 2023-10-28
PT3408292T (pt) 2023-07-19
US12297472B2 (en) 2025-05-13
US20200055900A1 (en) 2020-02-20
WO2017132580A2 (en) 2017-08-03
ES2949163T3 (es) 2023-09-26
AU2017211395A1 (en) 2018-09-06

Similar Documents

Publication Publication Date Title
DK3408292T3 (da) Splittede inteiner med ganske særlig splejseaktivitet
DK3349580T3 (da) Hepatitis b kerneproteinmodulatorer
PL3491450T3 (pl) Naświetlanie linią laserową
DK3292141T3 (da) Fusionsproteiner
EP3302225A4 (en) CONDUCTIVE OPTICAL ELEMENT
DK3532768T3 (da) Pladslys
EP3323609A4 (en) OPTICAL LAMINATE
EP3574547C0 (en) WAVEGUIDE ASSEMBLY
EP3333619A4 (en) OPTICAL MODULATOR
EP3384346A4 (en) ELECTROCHROMIC ELEMENT
DK3163339T3 (da) Polariseringsbevarende multikernefiber
EP3553214A4 (en) ELECTRET FIBER SHEET
EP3382430A4 (en) OPTICAL ELEMENT
DK3246736T3 (da) Optisk fiber
EP3457205A4 (en) ELECTROCHROMIC ELEMENT
EP3646319A4 (en) VOICE INTERFACE PURCHASING SYSTEM
DK3687825T3 (da) Optisk sikkerhedselement
EP3470898A4 (en) OPTICAL CONNECTOR
EP3402856A4 (en) OPTICAL ADHESIVE
EP3546997A4 (en) OPTICAL FIBER FUSION SPLICE DEVICE
EP3540496A4 (en) MOBILE REFLECTIVE ELEMENT
DE112015006555A5 (de) Positioniersystem mit wicklungsanordnung
DK3435126T3 (da) Optisk fiber
EP3467557A4 (en) OPTICAL CONNECTOR
EP3519383C0 (en) RETINOID DERIVATIVES WITH ANTITUMOR ACTIVITY